Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib

Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib

US Patent 9314522 · Granted Apr 19, 2016

Estimated economic value: $14,478,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide ligands specific for Nectin-42025
Multimeric bicyclic peptide ligands2025
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2025
Bicyclic peptide ligands specific for CD1372024
Bicyclic peptide ligands specific for nectin-42024
Bicyclic peptide ligands specific for OX402023
Multimeric bicyclic peptide ligands2023
Monoclonal antibodies against HER2 epitope and methods of use thereof2022
CD37-binding molecules and immunoconjugates thereof2022
CD37-binding molecules and immunoconjugates thereof2022
Bicyclic peptide ligands specific for Nectin-42022
Heterotandem bicyclic peptide complexes2022